510(k) · Cleared
ClearedPro Osteon 500R
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Ebi, L.P. · MQV Filler, Bone Void, Calcium Compound
Cleared on Apr 18, 2007 as substantially equivalent to K990131 (Interpore Cross Intl., 1999) and 6 other predicates after a 166-day review. Its family tree reaches back 5 generations to 1996.
- Decided
- Apr 18, 2007
- Review
- 166 days
- Class
- Class II
- Product code
- MQV
- Recalls
- None
- Predicates
- 7
Its longest line of descent runs back 5 generations to K960978 (1996). 23 ancestors in all. No later device cites it as a predicate yet.
- Root · 5 generations backK960978 Wright Plaster of Paris Pellets (Subject to Revision)Wrightmedicaltechnologyinc · 1996
- 4 generations backK980817 Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model…Interpore Intl. · 1998
- 3 generations backK013960 Apatight HA-Bone Graft SubstituteCerabio, LLC · 2002
- 2 generations backK030178 Calcigen Psi Bone Graft SubstituteBiomet, Inc. · 2003
- 1 generation backK032286 Calcigen Psi Bone Graft SubstituteBiomet Orthopedics, Inc. · 2003
- This deviceK063346 Pro Osteon 500REbi, L.P. · 2007
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −5 | K960978 | Wright Plaster of Paris Pellets (Subject to Revision) | Wrightmedicaltechnologyinc | 1996 | — |
| −4 | K980817 | Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05… | Interpore Intl. | 1998 | — |
| −3 | K013960 | Apatight HA-Bone Graft Substitute | Cerabio, LLC | 2002 | — |
| −2 | K030178 | Calcigen Psi Bone Graft Substitute | Biomet, Inc. | 2003 | — |
| −1 | K032286 | Calcigen Psi Bone Graft Substitute | Biomet Orthopedics, Inc. | 2003 | — |
| 0 (this device) | K063346 | Pro Osteon 500R | Ebi, L.P. | 2007 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1997 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 7 | 0 |
| 2003 | 3 | 0 |
| 2004 | 1 | 0 |
| 2005 | 2 | 0 |
| 2006 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new MQV device
- #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (7)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K990131 | Pro Osteon Implant 500R Resorbable Bone Graft SubstituteSummary page 1…sslificartlon Name: Filler, Bone Void, Caldium Compound (888.3045) Legally Marketed Devices To Which Substantial Equivalence Is ClaImed: * Pro Osteon® SOOR - K990131/K980817 (Interpore Cross International) * Cakcigent " PSI - K032286 (Biomet Orthopedics) * Marrow Plus (M+T… | 1999 |
| * | K980817 | Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05, 5RG10…Summary page 1…rtlon Name: Filler, Bone Void, Caldium Compound (888.3045) Legally Marketed Devices To Which Substantial Equivalence Is ClaImed: * Pro Osteon® SOOR - K990131/K980817 (Interpore Cross International) * Cakcigent " PSI - K032286 (Biomet Orthopedics) * Marrow Plus (M+Th) - KOS… | 1998 |
| * | K032286 | Calcigen Psi Bone Graft SubstituteSummary page 1…keted Devices To Which Substantial Equivalence Is ClaImed: * Pro Osteon® SOOR - K990131/K980817 (Interpore Cross International) * Cakcigent " PSI - K032286 (Biomet Orthopedics) * Marrow Plus (M+Th) - KOS 1695 (Berkeley Advanced Blornaterials, Inc.) * PolyGraft'~'… | 2003 |
| * | K051695 | Marrow Plus (M+) | 2005 |
| * | K040047 | Polygraft BGS; Bone Graft SubstituteSummary page 1…igent " PSI - K032286 (Biomet Orthopedics) * Marrow Plus (M+Th) - KOS 1695 (Berkeley Advanced Blornaterials, Inc.) * PolyGraft'~'/rufflock' m BGS - K040047 (OsteoBlologics, Inc.) * NBCPT m- K043005/K051774 (Biomatlante) Device Description: Pro Osteon® 50CR Resorbable Bone G… | 2004 |
| * | K043005 | Modification to MBCPSummary page 1…* Marrow Plus (M+Th) - KOS 1695 (Berkeley Advanced Blornaterials, Inc.) * PolyGraft'~'/rufflock' m BGS - K040047 (OsteoBlologics, Inc.) * NBCPT m- K043005/K051774 (Biomatlante) Device Description: Pro Osteon® 50CR Resorbable Bone Graft Substitute isan osteoconductive porous implant s… | 2005 |
| * | K051774 | MBCPSummary page 1…w Plus (M+Th) - KOS 1695 (Berkeley Advanced Blornaterials, Inc.) * PolyGraft'~'/rufflock' m BGS - K040047 (OsteoBlologics, Inc.) * NBCPT m- K043005/K051774 (Biomatlante) Device Description: Pro Osteon® 50CR Resorbable Bone Graft Substitute isan osteoconductive porous implant sImilar I… | 2006 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 11 years and passes through 6 companies; a new generation was cleared every 2.3 years on median.
- 1 of the 23 ancestors has a recall of any class.
- 17 other devices also cite its predicate K990131.
How does its category compare?
All MQV devicesMQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.
FDA decisions per year · MQV
14in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · MQV
57in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · MQV
1in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · MQV
57in 2025
MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 35 | 144 | 5 | 67 |
| 2008 | 32 | 102 | 3 | 71 |
| 2009 | 23 | 180 | 1 | 81 |
| 2010 | 17 | 147 | 0 | 68 |
| 2011 | 16 | 92 | 6 | 114 |
| 2012 | 9 | 107 | 3 | 149 |
| 2013 | 12 | 197 | 2 | 223 |
| 2014 | 20 | 153 | 0 | 111 |
| 2015 | 18 | 184 | 0 | 125 |
| 2016 | 8 | 214 | 1 | 106 |
| 2017 | 17 | 124 | 1 | 107 |
| 2018 | 23 | 124 | 2 | 86 |
| 2019 | 13 | 90 | 0 | 65 |
| 2020 | 15 | 132 | 1 | 126 |
| 2021 | 8 | 88 | 0 | 101 |
| 2022 | 9 | 118 | 0 | 47 |
| 2023 | 21 | 74 | 3 | 120 |
| 2024 | 28 | 55 | 2 | 68 |
| 2025 | 14 | 57 | 1 | 57 |
| 2026 | 5 | 96 | 4 | — |
What is it indicated for?
PRO OSTEON® 500R Resorbable Bone Graft Substitute is indicated only for bony voids or gaps that are not intrinsic to the stability of the bony structure. PRO OSTEON® 500R is indicated to be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. PRO OSTEON® 500R can be combined with autogenous bone marrow aspirate, autogenous blood, and/or sterile fluids (saline or Ringer's solution). The product provides a bone void filler that resorbs and is replaced with bone during the healing process.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K063346 · printed Nov 4, 2026
Cite this page
510(k) Report. “K063346: Pro Osteon 500R.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K063346
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026